TNGX: Tango Therapeutics, Inc. Stock

by  •  • Comments Off on TNGX: Tango Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 201.08
Enterprise Value ($M) 131.55
Book Value ($M) 199.52
Book Value / Share 1.85
Price / Book 1.01
NCAV ($M) 149.37
NCAV / Share 1.38
Price / NCAV 1.35

Profitability (mra)
Return on Invested Capital (ROIC) -0.55
Return on Assets (ROA) -0.32
Return on Equity (ROE) -0.51

Liquidity (mrq)
Quick Ratio 6.98
Current Ratio 6.98

Balance Sheet (mrq) ($M)
Current Assets 266.34
Assets 316.49
Liabilities 116.97
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 42.07
Operating Income -145.59
Net Income -130.30

Cash Flow Statement (mra) ($M)
Cash From Operations -131.50
Cash from Investing 86.13
Cash from Financing 47.66

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A EcoR1 Capital, LLC 9.90 -20.25
01-02 13D/A BCTG Holdings, LLC 10.00 -29.40
12-06 13G/A Fmr Llc 0.00 -99.86
11-20 13G TCG Crossover GP II, LLC 9.80
11-07 13D/A Boxer Capital Management, LLC 6.50 0.00
10-15 13D/A Boxer Asset Management Inc. 0.00
10-15 13D/A Boxer Capital, LLC 7.80
09-04 13D/A Third Rock Ventures IV, L.P. 15.90 -12.20
04-08 13G/A Southpoint Capital Advisors LP 4.90 0.00
2024-02-13 13G/A Gilead Sciences Inc 4.80 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-11 243,279 664,477 36.61
2025-03-10 209,719 654,107 32.06
2025-03-07 154,543 606,580 25.48
2025-03-06 136,308 523,194 26.05

(click for more detail)

Similar Companies
TCRX – TScan Therapeutics, Inc. TKNO – Alpha Teknova, Inc.
TLPH – Talphera, Inc. TRDA – Entrada Therapeutics, Inc.
TRVI – Trevi Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io